7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Neurotrauma Biomarker Levels and Adverse Symptoms Among Military and Law Enforcement Personnel Exposed to Occupational Overpressure Without Diagnosed Traumatic Brain Injury

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This cohort study evaluates associations between exposure to low-level overpressure, elevated serum levels of neurotrauma biomarkers, and concussion-like symptoms in military and law enforcement personnel without a diagnosed traumatic brain injury.

          Key Points

          Question

          Are neurotrauma biomarkers associated with adverse symptoms reported by military and law enforcement personnel exposed to low-level overpressure, an excess of normal atmospheric pressure, in the absence of a clinically defined brain injury?

          Findings

          In this cohort study of 106 male active-duty US Army or law enforcement personnel exposed to low-level atmospheric overpressure and 30 control individuals, serum levels of ubiquitin carboxyl hydrolase (UCH)–L1, tau, amyloid β (Aβ)–40, and Aβ-42 were elevated in personnel exposed to overpressure compared with control individuals; Aβ-42 was associated with self-reported ear ringing and memory problems.

          Meaning

          The findings suggest that elevated levels of neurotrauma biomarkers are associated with overpressure exposure and concussion-like symptoms among active-duty military and law enforcement personnel who are outwardly healthy and cleared to perform duties.

          Abstract

          Importance

          There is a scientific and operational need to define objective measures of exposure to low-level overpressure (LLOP) and concussion-like symptoms among persons with specialized occupations.

          Objective

          To evaluate serum levels of neurotrauma biomarkers and their association with concussion-like symptoms reported by LLOP-exposed military and law enforcement personnel who are outwardly healthy and cleared to perform duties.

          Design, Setting, and Participants

          This retrospective cohort study, conducted from January 23, 2017, to October 21, 2019, used serum samples and survey data collected from healthy, male, active-duty military and law enforcement personnel assigned to operational training at 4 US Department of Defense and civilian law enforcement training sites. Personnel aged 18 years or older with prior LLOP exposure but no diagnosed traumatic brain injury or with acute blast exposure during sampling participated in the study. Serum samples from 30 control individuals were obtained from a commercial vendor.

          Main Outcomes and Measures

          Serum levels of glial fibrillary acidic protein, ubiquitin carboxyl hydrolase (UCH)-L1, neurofilament light chain, tau, amyloid β (Aβ)-40, and Aβ-42 from a random sample (30 participants) of the LLOP-exposed cohort were compared with those of 30 age-matched controls. Associations between biomarker levels and self-reported symptoms or operational demographics in the remainder of the study cohort (76 participants) were assessed using generalized linear modeling or Spearman correlations with age as a covariate.

          Results

          Among the 30 randomly sampled participants (mean [SD] age, 32 [7.75] years), serum levels of UCH-L1 (mean difference, 4.92; 95% CI, 0.71-9.14), tau (mean difference, 0.16; 95% CI, −0.06 to 0.39), Aβ-40 (mean difference, 138.44; 95% CI, 116.32-160.56), and Aβ-42 (mean difference, 4.97; 95% CI, 4.10-5.83) were elevated compared with those in controls. Among the remaining cohort of 76 participants (mean [SD] age, 34 [7.43] years), ear ringing was reported by 44 (58%) and memory or sleep problems were reported by 24 (32%) and 20 (26%), respectively. A total of 26 participants (34%) reported prior concussion. Amyloid β-42 levels were associated with ear ringing ( F 1,72 = 7.40; P = .008) and memory problems ( F 1,72 = 9.20; P = .003).

          Conclusions and Relevance

          The findings suggest that long-term LLOP exposure acquired during occupational training may be associated with serum levels of neurotrauma biomarkers. Assessment of biomarkers and concussion-like symptoms among personnel considered healthy at the time of sampling may be useful for military occupational medicine risk management.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: not found
          • Article: not found

          Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            An update on diagnostic and prognostic biomarkers for traumatic brain injury

            Traumatic brain injury (TBI) is a major worldwide neurological disorder of epidemic proportions. To date, there are still no FDA-approved therapies to treat any forms of TBI. Encouragingly, there are emerging data showing that biofluid-based TBI biomarker tests have the potential to diagnose the presence of TBI of different severities including concussion, and to predict outcome. Areas covered: The authors provide an update on the current knowledge of TBI biomarkers, including protein biomarkers for neuronal cell body injury (UCH-L1, NSE), astroglial injury (GFAP, S100B), neuronal cell death (αII-spectrin breakdown products), axonal injury (NF proteins), white matter injury (MBP), post-injury neurodegeneration (total Tau and phospho-Tau), post-injury autoimmune response (brain antigen-targeting autoantibodies), and other emerging non-protein biomarkers. The authors discuss biomarker evidence in TBI diagnosis, outcome prognosis and possible identification of post-TBI neurodegernative diseases (e.g. chronic traumatic encephalopathy and Alzheimer's disease), and as theranostic tools in pre-clinical and clinical settings. Expert commentary: A spectrum of biomarkers is now at or near the stage of formal clinical validation of their diagnostic and prognostic utilities in the management of TBI of varied severities including concussions. TBI biomarkers could serve as a theranostic tool in facilitating drug development and treatment monitoring.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

              Axonal white matter injury is believed to be a major determinant of adverse outcomes following traumatic brain injury (TBI). We hypothesized that measurement of neurofilament light protein (NF-L), a protein found in long white-matter axons, in blood samples, may serve as a suitable biomarker for neuronal damage in TBI patients. To test our hypotheses, we designed a study in two parts: i) we developed an immunoassay based on Single molecule array technology for quantification of NF-L in blood, and ii) in a proof-of-concept study, we tested our newly developed method on serial serum samples from severe TBI (sTBI) patients (n = 72) and controls (n = 35). We also compared the diagnostic and prognostic utility of NF-L with the established blood biomarker S100B. NF-L levels were markedly increased in sTBI patients compared with controls. NF-L at admission yielded an AUC of 0.99 to detect TBI versus controls (AUC 0.96 for S100B), and increased to 1.00 at day 12 (0.65 for S100B). Importantly, initial NF-L levels predicted poor 12-month clinical outcome. In contrast, S100B was not related to outcome. Taken together, our data suggests that measurement of serum NF-L may be useful to assess the severity of neuronal injury following sTBI.
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                16 April 2021
                April 2021
                16 April 2021
                : 4
                : 4
                : e216445
                Affiliations
                [1 ]Brain Trauma Neuroprotection Branch, Center for Military Psychiatry and Neuroscience, Walter Reed Army Institute of Research, Silver Spring, Maryland
                [2 ]Blast Induced Neurotrauma Branch, Center for Military Psychiatry and Neuroscience, Walter Reed Army Institute of Research, Silver Spring, Maryland
                Author notes
                Article Information
                Accepted for Publication: February 26, 2021.
                Published: April 16, 2021. doi:10.1001/jamanetworkopen.2021.6445
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Boutté AM et al. JAMA Network Open.
                Corresponding Author: Angela M. Boutté, PhD, Brain Trauma Neuroprotection Branch, Center for Military Psychiatry and Neuroscience, Walter Reed Army Institute of Research, 503 Robert Grant Ave, Silver Spring, MD 20901 ( angela.m.boutte.civ@ 123456mail.mil ).
                Author Contributions: Drs Boutte and Carr had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Boutte, Thangavelu, Carr, Kamimori.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Boutte, Thangavelu, Nemes, Egnoto, Carr.
                Critical revision of the manuscript for important intellectual content: Boutte, LaValle, Carr, Kamimori.
                Statistical analysis: Boutte, Nemes, LaValle.
                Obtained funding: Boutte, Carr, Kamimori.
                Administrative, technical, or material support: Boutte, Nemes, LaValle, Egnoto, Carr, Kamimori.
                Supervision: Boutte, LaValle, Kamimori.
                Conflict of Interest Disclosures: Dr Boutte reported being the founder of Aries Biotech. No other disclosures were reported.
                Funding/Support: This work was supported by the Combat Casualty Care Research Program; the US Army Medical Research and Materiel Command Military Operational Medicine Research Program (Research Area Directorate 3); the Broad Agency Announcement Award (W81XWH-16-2-0001) from the Office of the Assistant Secretary of Defense for Health Affairs (Dr Kamimori); and an appointment to the Research Participation Program at the Walter Reed Army Institute of Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and US Army Medical Research and Development Command.
                Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Disclaimer: The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting true views of the Department of the Army or the Department of Defense.
                Additional Contributions: Deborah A. Shear, PhD, and Janice Gilsdorf, PhD (Brain Trauma Neuroprotection Branch, Walter Reed Army Institute for Research [WRAIR]), provided laboratory resources, guidance, and support; Tina Ndam, BS (Brain Trauma Neuroprotection Branch, WRAIR), performed Simoa biomarker assays; LTC William Washington, MD, and Beverly Vaughn, BA (Preventive Medicine Branch, WRAIR), provided access to SAS statistical software for analytical use; and the WRAIR field research team collected blood samples and survey data and formatted the data for analytical use. They did not receive compensation. We thank the military service members and law enforcement professionals who volunteered for this study as participants and for their service every day.
                Article
                zoi210212
                10.1001/jamanetworkopen.2021.6445
                8052592
                33861330
                bd886ce9-dc0f-4929-a792-aaa0f9e5dc12
                Copyright 2021 Boutté AM et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 24 November 2020
                : 26 February 2021
                Categories
                Research
                Original Investigation
                Online Only
                Neurology

                Comments

                Comment on this article